FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI
-
By
-
Kathryn Wighton
-
June 15, 2026
-
3 min
By
Kathryn Wighton
June 15, 2026
"The more AI changes what we do … the less able we are to check it.”
by Lisa Astor
October 1, 2026
Several FDA decisions across multiple specialties are expected this month.
August 28, 2026